Spinal fusion: Will the Medtronic/Kyphon deal quell ferment in the orthopedic-implant market?
I didn’t write about Medtronics’ $3.9 billion acquisition of Kyphon when it was announced almost two weeks ago, largely because it seemed to be a pretty straightforward merger of two big public companies with relatively few implications for the venture medical-device business.
The good folks at the In Vivo Blog beg to differ, and weighed in earlier this week with a sharp analysis of the deal. To summarize, Kyphon was seen as an upstart in the… Continue Reading
Kyphon to buy St. Francis for $525M, boosting struggling venture firm USVP
Updated
St. Francis Medical Technologies, of Sunnyvale, a company that treats spinal injuries, will be acquired Kyphon of Sunnyvale, for as much as $725 million, the companies said.
This must be especially welcome for Silicon Valley venture firm US Venture Partners, a backer of St. Francis which has performed poorly lately (see data below). This deal comes just as St. Francis was about to go public; the offer was too good for St. Francis’ private investors to… Continue Reading